Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 0527-3311

8 FDA label images from Lannett Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 0527-3311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ichemical-structure (Methylphenidate Hydrochloride 1)

Ichemical-structure (Methylphenidate Hydrochloride 1)
Chemical structure diagram of Methylphenidate Hydrochloride showing its molecular framework including a phenyl ring, methyl ester group, and piperidine ring with a hydrochloride component.*
FDA Label Image

Figure-1 (Methylphenidate Hydrochloride 2)

Figure-1 (Methylphenidate Hydrochloride 2)
A line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) between methylphenidate hydrochloride extended-release 18 mg once daily tablets and methylphenidate 5 mg taken three times daily. The graph shows concentration peaks and declines within a 32-hour timeframe.*
FDA Label Image

Figure-2 (Methylphenidate Hydrochloride 3)

Figure-2 (Methylphenidate Hydrochloride 3)
A bar chart comparing maximum symptoms on the Inattention/Overactivity Scale for Methylphenidate Hydrochloride Extended-Release Tablets once daily versus placebo across three studies. The vertical axis ranges from 0 (No Symptoms) to 15. Each study shows two bars: black for Methylphenidate Hydrochloride and white for placebo, with sample sizes indicated below.*
FDA Label Image

Figure-3 (Methylphenidate Hydrochloride 4)

Figure-3 (Methylphenidate Hydrochloride 4)
A line graph comparing combined attention subscores over 12 hours post initial dose between Methylphenidate Hydrochloride Extended-Release Tablets taken once daily and placebo. The vertical axis measures attention from 'More Attentive' to 'Less Attentive,' and the horizontal axis shows hours after dosing. Data points with error bars indicate mean and standard error for each group at multiple time points.*
FDA Label Image

18 mg 100 Count (Methylphenidate Hydrochloride 5)

18 mg 100 Count (Methylphenidate Hydrochloride 5)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP, 18 mg strength. The label indicates the dosage form as extended-release tablets, provides storage instructions, and specifies the manufacturer as Lannett Company, Inc. It includes warnings to keep medication out of reach of children and dispenses 100 tablets per bottle.*
FDA Label Image

27 mg 100 Count (Methylphenidate Hydrochloride 6)

27 mg 100 Count (Methylphenidate Hydrochloride 6)
Label for Methylphenidate Hydrochloride HCl Extended-Release Tablets, USP 27 mg, distributed by Lannett Company, Inc. The label shows dosage strength, quantity of 100 tablets, and instructions to dispense with accompanying Medication Guide. Storage conditions and safety warnings are included, along with the product's NDC 0527-3311-37.*
FDA Label Image

36 mg 100 Count (Methylphenidate Hydrochloride 7)

36 mg 100 Count (Methylphenidate Hydrochloride 7)
Methylphenidate Hydrochloride 36 mg extended-release tablets label from Lannett Company, Inc. The label indicates the oral dosage form, container holds 100 tablets, and states storage instructions along with medication guide dispensing information. Barcode and revision date of 07/21 are visible.*
FDA Label Image

54 mg 100 Count (Methylphenidate Hydrochloride 8)

54 mg 100 Count (Methylphenidate Hydrochloride 8)
Label for Methylphenidate Hydrochloride 54 mg extended-release tablets, USP, distributed by Lannett Company, Inc. The label includes dosage strength, storage instructions at 25°C (77°F), the requirement to dispense with a Medication Guide, and package size of 100 tablets. The NDC number 0527-3313-37 is visible alongside a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.